APA (7th ed.) Citation

Neuberger, M., Skladny, J., Goly, N., Wessels, F., Weiß, C., Egen, L., . . . Nuhn, P. (2022). Baseline modified Glasgow Prognostic Score (mGPS) predicts radiologic response and overall survival in metastatic hormone-sensitive prostate cancer treated with docetaxel chemotherapy. Anticancer research, 42(4), . https://doi.org/10.21873/anticanres.15668

Chicago Style (17th ed.) Citation

Neuberger, Manuel, et al. "Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Docetaxel Chemotherapy." Anticancer Research 42, no. 4 (2022). https://doi.org/10.21873/anticanres.15668.

MLA (9th ed.) Citation

Neuberger, Manuel, et al. "Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Docetaxel Chemotherapy." Anticancer Research, vol. 42, no. 4, 2022, https://doi.org/10.21873/anticanres.15668.